HMGA1 in pancreatic cancer is resistant to gemcitabine by an Akt-dependent mechanism, but stable short hairpin RNA targeting HMGA1 can resensitize drug-resistant cells 105. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.